FDA Device Recalls

Recalls /

#160235

Product

Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum, Ref R30164201 ZH01. Product Usage: Suitable for the use in slide agglutination tests to identify Shigella cultures presumptively for epidemiological and diagnostic purposes.

FDA product code
GNBAntisera, All Types, Shigella Spp.
Device class
Class 2
Medical specialty
Microbiology
Affected lot / code info
UDI 50560805009592. Kit lot #1465529, Bottle lot #1465528; Kit lot #2118879, Bottle lot #1847290; Kit lot #2173683, Bottle lot #1847290; Kit lot #2161363, Bottle lot #1847290; Kit lot #1984639, Bottle lot #1847290; Kit lot #1738564, Bottle lot#1738565; Kit lot #1971308, Bottle lot #1738565; Kit lot #1957305, Bottle lot #1738565; Kit lot #1947930, Bottle lot #1738565; and Kit lot #1847285, Bottle lot #1738565.

Why it was recalled

The serum may fail to agglutinate within the specified minimum reaction time.

Root cause (FDA determination)

Under Investigation by firm

Action the firm took

The recalling firm issued letters dated 12/8/2017 via regular mail. The letter identified the affected product, problem and actions to be taken. The risk to health is also explained. The customer is requested to notify any personnel who need to be aware of the potential for incorrect performance specification for the product. The customer is to inspect their stock and destroy any remaining inventory of the lots listed. They are to contact Customer Service or their local distributor for replacement. A response form was to be returned acknowledging receipt of the notice and disposal of the affected product. If the product was further distributed, the customer was requested to contact their downstream customers, advise them of the recall, and provide them a copy of the recall letter.

Recalling firm

Firm
Remel Inc
Address
12076 Santa Fe Trail Dr, Lenexa, Kansas 66215-3519

Distribution

Distribution pattern
US Nationwide Distribution

Timeline

Recall initiated
2017-12-08
Terminated
2020-07-22
Status

Source: openFDA Device Recall endpoint. Recall record ID #160235. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.